Internal Medicine, Pulmonary Disease · Stuart, FL
NPI
1770675530
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2221 SE Ocean Blvd, Suite 100
Stuart, FL, 34996
Phone (772) 283-4428
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.1M
23,861 services
Medicare patients, 2024
1,798
Average age 79
Drug cost, 2024
$3.2M
3,326 prescriptions
Company payments, 2025
$25K
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert M Dermarkarian was code 99490 (chronic, principal, and transitional care management), 6,687 times for 795 patients. In total Robert M Dermarkarian billed 23,861 services in 63 codes, and Medicare paid $1.1M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-01-07.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99490 Chronic, Principal, and Transitional Care Management | Office | 6,687 | 795 | $50.14 | $335K |
| J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | Office | 3,028 | 724 | $0.14 | $432 |
| 99214 Office E&M - Established | Office | 3,008 | 1,407 | $100.11 | $301K |
| 99458 E&M - Miscellaneous | Office | 2,331 | 195 | $31.24 | $73K |
| 99457 E&M - Miscellaneous | Office | 1,651 | 201 | $38.85 | $64K |
| 99454 E&M - Miscellaneous | Office | 1,530 | 198 | $37.96 | $58K |
| 94640 Treatment - Miscellaneous | Office | 753 | 720 | $6.46 | $4,865 |
| 94729 Pulmonary Function Testing | Office | 751 | 724 | $42.96 | $32K |
| 94727 Pulmonary Function Testing | Office | 751 | 724 | $34.41 | $26K |
| 94060 Pulmonary Function Testing | Office | 747 | 720 | $30.72 | $23K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 646 | 362 | $39.08 | $25K |
| 99487 Chronic, Principal, and Transitional Care Management | Office | 268 | 138 | $109.54 | $29K |
| 94664 E&M - Miscellaneous | Office | 202 | 189 | $13.52 | $2,731 |
| 99489 Chronic, Principal, and Transitional Care Management | Office | 196 | 51 | $56.02 | $11K |
| 99204 Office E&M - New | Office | 174 | 174 | $123.52 | $21K |
By year: 2022 $747K for 14,427 services; 2023 $960K for 19,901 services; 2024 $1.1M for 23,861 services.
Medicare prescription drug claims, 2024
In 2024, the drug Robert M Dermarkarian prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 511 prescriptions and refills. In total Robert M Dermarkarian wrote 3,326 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 511 | 918 | 128 | $566K |
| Montelukast Sodium Generic | 382 | 1,103 | 126 | $6,283 |
| Breo Ellipta Fluticasone/Vilanterol | 259 | 435 | 65 | $169K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 211 | 275 | 91 | $7,132 |
| Prednisone Generic | 202 | 320 | 129 | $953 |
| Amlodipine Besylate Generic | 71 | 182 | 26 | $619 |
| Ofev Nintedanib Esylate | 69 | 77 | Under 11 | $1.0M |
| Fluticasone Propionate Generic | 56 | 146 | 29 | $1,147 |
| Spiriva Respimat Tiotropium Bromide | 52 | 112 | 15 | $57K |
| Ventolin Hfa Albuterol Sulfate | 45 | 49 | 26 | $2,644 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 45 | 81 | 14 | $34K |
| Azithromycin Generic | 43 | 46 | 35 | $412 |
| Levothyroxine Sodium Generic | 42 | 112 | Under 11 | $1,625 |
| Metoprolol Succinate Generic | 40 | 108 | 14 | $370 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 39 | 59 | Under 11 | $249 |
Brand drugs: - claims; generic drugs: 1,791 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert M Dermarkarian $25K ($25K in general payments such as food, travel and fees) from 23 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $20K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 42 | $20K |
| Roche Diagnostics Corporation ROG.SW | 1 | $2,704 |
| Actelion Pharmaceuticals US, Inc. JNJ | 13 | $466 |
| United Therapeutics Corporation UTHR | 7 | $322 |
| GlaxoSmithKline, LLC. GSK | 17 | $316 |
| Insmed, Inc. INSM | 15 | $309 |
| Verona Pharma, Inc. VRNA | 8 | $203 |
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $122 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $113 |
| Merck Sharp & Dohme LLC MRK | 5 | $109 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.